| 发明名称 |
Solid Solution Compositions and Use in Chronic Inflammation |
| 摘要 |
The present specification discloses pharmaceutical compositions, methods of preparing such pharmaceutical compositions, and methods and uses of treating a chronic inflammation and/or an inflammatory disease in an individual using such pharmaceutical compositions. |
| 申请公布号 |
US2014162988(A1) |
申请公布日期 |
2014.06.12 |
| 申请号 |
US201414155108 |
申请日期 |
2014.01.14 |
| 申请人 |
Biocopea Limited |
发明人 |
Bannister Robin M.;Brew John;Reiley, III Richard R.;Caparros Wanderley Wilson |
| 分类号 |
A61K47/26;A61K47/10;A61K31/357;A61K47/14;A61K31/616;A61K47/22;A61K47/12;A61K31/196;A61K31/222;A61K31/167;A61K31/121;A61K31/522;A61K31/137;A61K31/366;A61K31/4184;A61K31/192 |
主分类号 |
A61K47/26 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A solid solution pharmaceutical composition comprising: a) one or more therapeutic compounds comprising about 5% to 55% by weight of the pharmaceutical composition; b) one or more room temperature solid lipids comprising about 30% to about 75% by weight of the pharmaceutical composition; c) one or more room temperature liquid lipids comprising about 1% to about 20% by weight of the pharmaceutical composition, wherein the solid solution pharmaceutical composition has a melting point of 30° C. or higher.
|
| 地址 |
London GB |
